Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome

NCT02049229 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
1800
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Hospital District of Satakunta